Michael J. Kamdar
Amministratore Delegato presso Molecular Assemblies, Inc.
Provenienza dei contatti di primo grado di Michael J. Kamdar
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Molecular Assemblies, Inc.
 Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA.
9
| Holding Company | Biotechnology | 9 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Medipacs, Inc.
 Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA.
6
| Holding Company | Electronic Equipment/Instruments | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael J. Kamdar tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Human Resources Officer | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Founder Founder | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Biotechnology | Founder Founder | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
RxActuator, Inc.
 RxActuator, Inc. Medical SpecialtiesHealth Technology RxActuator, Inc. engages in the manufacture of proprietary veterinary medical devices. It offers a wearable infusion pump for animals. The company was founded by Mark Banister in 2017 and is headquartered in Tucson, AZ. | Medical Specialties | Director/Board Member Founder | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AC IMMUNE SA | Pharmaceuticals: Major | Chairman | |
| University of Massachusetts Lowell | College/University | Undergraduate Degree | |
| ALBEMARLE CORPORATION | Chemicals: Specialty | Corporate Officer/Principal | |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Chairman | |
| Wesleyan University | College/University | Undergraduate Degree | |
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
| New York University | College/University | Doctorate Degree | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Director/Board Member | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Doctorate Degree | |
| LaSalle University | College/University | Undergraduate Degree | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| HTG MOLECULAR DIAGNOSTICS, INC. | Miscellaneous Commercial Services | Chairman | |
| Arizona-Sonora Desert Museum, Inc. | Director/Board Member | ||
Kurzweil Technologies, Inc.
 Kurzweil Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Kurzweil Technologies, Inc. provides research, development, and marketing services. Its affiliated companies include FatKat, Kurzweil Educational Systems, and Kurzweil Music Systems. Kurzweil Technologies was co-founded by Raymond C. Kurzweil and Aaron Kleiner in 1995 and is headquartered in Wellesley Hills, MA | Miscellaneous Commercial Services | Founder | |
| Southern Arizona Leadership Council | Director/Board Member | ||
Tempronics, Inc.
 Tempronics, Inc. SemiconductorsElectronic Technology Tempronics, Inc. manufactures and develops thermoelectric systems. Its thermostatic devices are used in cooling and power generation equipment, including compressors, gas turbines, steam turbines and electrical generators. The firm serves air conditioning, automotive, aviation, refrigerator, thermal management and solar energy markets. The company was founded by Tarek Makansi and Mark Nelsen Evers in 2006 and is headquartered in Tucson, AZ. | Semiconductors | Director/Board Member | |
SynCardia Systems LLC
 SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Medical Specialties | Chairman | |
Calimmune, Inc.
 Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Svizzera | 2 |
| Paesi Bassi | 2 |
| Regno Unito | 2 |
| Canada | 2 |
Settori
| Health Technology | 27 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Finance | 3 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 142 |
| Corporate Officer/Principal | 55 |
| Chairman | 28 |
| Chief Tech/Sci/R&D Officer | 28 |
| Founder | 26 |
Contatti più connessi
| Insiders | |
|---|---|
| George Scangos | 33 |
| Steven Holtzman | 28 |
| Harry Allan George | 27 |
| Douglas Williams | 25 |
| Marios Fotiadis | 25 |
| John Nicols | 14 |
| Todd Peterson | 14 |
| Larry G. Stambaugh | 14 |
| Stephen Worland | 12 |
| Carmine Stengone | 11 |
| Jeffrey Raikes | 11 |
| James R. Thomas | 10 |
| Helge Bastian | 10 |
| Neil James Clendeninn | 9 |
| Siegfried Reich | 8 |
- Borsa valori
- Insiders
- Michael J. Kamdar
- Connessioni Società
